Denna sida på svenska
Loading profile information...

Publications

Impact of genomic stability on protein expression in endometrioid endometrial cancer
Lomnytska Mi, Becker S, Gemoll T, Lundgren C, Habermann J, Olsson A, et al
BRITISH JOURNAL OF CANCER 2012;106(7):1297-305

Carcinoma of the cervical stump: Fifty years of experience
Hellstrom Ac, Hellman K, Pettersson Bf, Andersson S
ONCOLOGY REPORTS 2011;25(6):1651-4

Cervical cancer in the screening era: who fell victim in spite of successful screening programs?
Pettersson Bf, Hellman K, Vaziri R, Andersson S, Hellstrom Ac
JOURNAL OF GYNECOLOGIC ONCOLOGY 2011;22(2):76-82

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
Lomnytska Mi, Becker S, Bodin I, Olsson A, Hellman K, Hellstrom Ac, et al
BRITISH JOURNAL OF CANCER 2011;104(1):110-9

Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities
Dillner L, Kemetli L, Elfgren K, Bogdanovic G, Andersson P, Carlsten-thor A, et al
INTERNATIONAL JOURNAL OF CANCER 2011;129(1):151-9

Diagnostic protein marker patterns in squamous cervical cancer
Lomnytska Mi, Becker S, Hellman K, Hellstrom Ac, Souchelnytskyi S, Mints M, et al
PROTEOMICS CLINICAL APPLICATIONS 2010;4(1):17-31

E6/E7 mRNA expression analysis: A test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure
Hovland S, Muller S, Skomedal H, Mints M, Bergstrom J, Wallin Kl, et al
INTERNATIONAL JOURNAL OF ONCOLOGY 2010;36(6):1533-9

Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden
Ostensson E, Froberg M, Hjerpe A, Zethraeus N, Andersson S
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2010;89(10):1316-25

Invasive Carcinoma of the Uterine Cervix Associated With Pregnancy 90 Years of Experience
Pettersson Bf, Andersson S, Hellman K, Hellstrom Ac
CANCER 2010;116(10):2343-9

Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom La, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, et al
INTERNATIONAL JOURNAL OF CANCER 2010;127(8):1923-30

Slumbering mucosal immune response in the cervix of human papillomavirus DNA-positive and -negative women
Wendel Sb, Kaldensjo T, Peterson P, Andersson S, Broliden K, Hirbod T
INTERNATIONAL JOURNAL OF ONCOLOGY 2010;37(6):1565-73

Teaching pelvic examination technique using professional patients: a controlled study evaluating students' skills
Wanggren K, Jonassen Af, Andersson S, Pettersson G, Gemzell-danielsson K
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2010;89(10):1298-303

Abundant and Superficial Expression of C-Type Lectin Receptors in Ectocervix of Women at Risk of HIV Infection
Hirbod T, Kaldensjo T, Lopalco L, Klareskog E, Andersson S, Uberti-foppa C, et al
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2009;51(3):239-47

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
Brismar-wendel S, Froberg M, Hjerpe A, Andersson S, Johansson B
BRITISH JOURNAL OF CANCER 2009;101(3):511-7

Detection of Genomic Amplification of the Human Telomerase Gene TERC, a Potential Marker for Triage of Women with HPV-Positive, Abnormal Pap Smears
Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, et al
AMERICAN JOURNAL OF PATHOLOGY 2009;175(5):1831-47

Differential tissue-specific protein markers of vaginal carcinoma
Hellman K, Alaiya Aa, Becker S, Lomnytska M, Schedvins K, Steinberg W, et al
BRITISH JOURNAL OF CANCER 2009;100(8):1303-14

Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping
Brismar S, Johansson B, Borjesson M, Arbyn M, Andersson S
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2009;201(1):17.e1-8

Hysteroscopic female sterilization with Essure (R) in an outpatient setting
Andersson S, Eriksson S, Mints M
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2009;88(6):743-6

Laser capture microdissection of cervical human papillomavirus infections: Copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation
Kalantari M, Garcia-carranca A, Morales-vazquez Cd, Zuna R, Montiel Dp, Calleja-macias Ie, et al
VIROLOGY 2009;390(2):261-7

Mutation of PIK3CA: Possible risk factor for cervical carcinogenesis in older women
Cui B, Zheng B, Zhang X, Stendahl U, Andersson S, Wallin Kl
INTERNATIONAL JOURNAL OF ONCOLOGY 2009;34(2):409-16

Expression of p16(INK4a) and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma
Muller S, Flores-staino C, Skyldberg B, Hellstrom Ac, Johansson B, Hagmar B, et al
INTERNATIONAL JOURNAL OF ONCOLOGY 2008;32(2):333-40

Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities
Froberg M, Johansson B, Hjerpe A, Andersson S
BRITISH JOURNAL OF CANCER 2008;99(4):563-8

A comparison of liquid-based cytology and Pap smear as a screening method for cervical cancer
Zhu J, Norman I, Elfgren K, Gaberi V, Hagmar B, Hjerpe A, et al
ONCOLOGY REPORTS 2007;18(1):157-60

Expression of aquaporin-1 in endometrial blood vessels in menorrhagia
Mints M, Hildenbrand A, Lalitkumar Lpg, Andersson S, Nielsen S, Gemzell-danielsson K, et al
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2007;19(3):407-11

p16(INK4a) immunocytochemistry in liquid-based cervical cytology: Is it feasible for clinical use?
Norman I, Brismar S, Zhu J, Gaberi V, Hagmar B, Hjerpe A, et al
INTERNATIONAL JOURNAL OF ONCOLOGY 2007;31(6):1339-43

Thermal balloon ablation for the treatment of menorrhagia in an outpatient setting
Andersson S, Mints M
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2007;86(4):480-3

Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and P16(INK4a)
Andersson S, Hansson B, Norman I, Gaberi V, Mints M, Hjerpe A, et al
INTERNATIONAL JOURNAL OF ONCOLOGY 2006;29(3):705-11

Expression of p16(INK4A) in relation to histopathology and viral load of 'high-risk' HPV types in cervical neoplastic lesions
Andersson S, Wangsa D, Flores-staino C, Safari H, Mints M, Hjerpe A, et al
EUROPEAN JOURNAL OF CANCER 2006;42(16):2815-20

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
Andersson S, Wallin Kl, Hellstrom Ac, Morrison Le, Hjerpe A, Auer G, et al
BRITISH JOURNAL OF CANCER 2006;95(3):331-8

Miniconization procedure with C-LETZ conization electrode for treatment of cervical intraepithelial neoplasia: A Swedish study
Mints M, Gaberi V, Andersson S
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2006;85(2):218-23

p16(INK4a) and laminin-5 gamma 2 chain expression during the progression of cervical neoplasia
Wang Jl, Andersson S, Li X, Hellstrom Ac, Auer G, Angstrom T, et al
ACTA ONCOLOGICA 2006;45(6):676-84

Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix
Erlandsson F, Martinsson-ahlzen Hs, Wallin Kl, Hellstrom Ac, Andersson S, Zetterberg A
BRITISH JOURNAL OF CANCER 2006;94(7):1045-50

The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas
Andersson S, Hellstrom Ac, Ren Zp, Wilander E
MEDICAL ONCOLOGY 2006;23(1):113-9

Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior
Hirbod T, Nilsson J, Andersson S, Uberti-foppa C, Ferrari D, Manghi M, et al
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2006;43(2):137-43

A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities
Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2005;84(10):996-1000

The clinicopathologic significance of laminin-5 gamma 2 chain expression in cervical squamous carcinoma and adenocarcinoma
Andersson S, Hellstrom Ac, Angstrom T, Stendahl U, Auer G, Wallin Kl
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2005;15(6):1065-72

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
Andersson S, Safari H, Mints M, Lewensohn-fuchs I, Gyllensten U, Johansson B
BRITISH JOURNAL OF CANCER 2005;92(12):2195-200

Choriocarcinoma presented as a vaginal tumor
Andersson S, Rylander E, Flam F
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2004;83(8):776-7

The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies - A study with human papillomavirus deoxyribonucleic acid sequence analysis
Andersson S, Mints M, Sallstrom J, Wilander E
CANCER DETECTION AND PREVENTION 2004;29(1):37-41

Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection
Andersson S, Larson B, Hjerpe A, Silfversward C, Sallstrom J, Wilander E, et al
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2003;82(10):960-5

Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing
Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, et al
ONCOLOGY REPORTS 2003;10(1):175-9

The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E
EUROPEAN JOURNAL OF CANCER 2001;37(2):246-50

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas
Andersson S, Rylander E, Strand A, Sallstrom J, Wilander E
BRITISH JOURNAL OF CANCER 2001;85(8):1153-6

Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions
Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sallstrom J, et al
BRITISH JOURNAL OF CANCER 2000;83(3):307-10

Show all publications